Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Daniela Klarica"'
Autor:
Sridurga Mithraprabhu, Jay Hocking, Malarmathy Ramachandran, Kawa Choi, Daniela Klarica, Tiffany Khong, John Reynolds, Andrew Spencer
Publikováno v:
Cancers, Vol 11, Iss 7, p 917 (2019)
Mutational characterisation utilising plasma (PL)-derived circulating tumour DNA (ctDNA) in multiple myeloma (MM) has been recently described. Mutational analyses of paired bone marrow (BM) MM cell DNA and ctDNA from 76 patients (n = 24, new diagnosi
Externí odkaz:
https://doaj.org/article/835c94fed2194206aafefbb69cc36c62
Autor:
Erica M. Wood, Elizabeth Moore, Tracy King, Daniela Klarica, P. Joy Ho, Hang Quach, Andrew Spencer, H. Miles Prince, Zoe McQuilten, Rasa Ruseckaite
Publikováno v:
American Journal of Hematology. 95
Autor:
A. P. Nair, Jenny Muirhead, Krystal Bergin, Jane S Hocking, David J. Curtis, John V. Reynolds, Sue Morgan, Malgorzata Gorniak, Patricia Walker, Tongted Das, Anna Kalff, Andrew Spencer, Daniela Klarica, Sharon Avery, Sushrut Patil
Publikováno v:
Bone Marrow Transplantation. 52:839-845
High-risk (HR) multiple myeloma (MM) has poor outcomes with conventional therapy. Tandem autologous-non-myeloablative (NMA) allogeneic stem cell transplantation (autologous stem cell transplantation (ASCT)-NMA allogeneic SCT) is potentially curative
Autor:
Jay Hocking, Malarmathy Ramachandran, Kawa Choi, Tiffany Khong, Sridurga Mithraprabhu, Andrew Spencer, John V. Reynolds, Daniela Klarica
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e79-e80
Autor:
Tracy King, Daniela Klarica, Erica M. Wood, Hang Quach, P. Joy Ho, Alicia Snowden, Zoe McQuilten, H. Miles Prince, Elizabeth Moore, Andrew Spencer, Rasa Ruseckaite
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e340-e341
Autor:
Kerin Young, Jacqueline Jagger, Hayley Beer, Carmel Woodrow, Julija Sipavicius, Daniela Klarica, Tracy King
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e345-e346
Autor:
Malarmathy Ramachandran, Kawa Choi, John V. Reynolds, Sridurga Mithraprabhu, Tiffany Khong, Daniela Klarica, Andrew Spencer, Jay Hocking
Publikováno v:
Cancers
Cancers, Vol 11, Iss 7, p 917 (2019)
Volume 11
Issue 7
Cancers, Vol 11, Iss 7, p 917 (2019)
Volume 11
Issue 7
Mutational characterisation utilising plasma (PL)-derived circulating tumour DNA (ctDNA) in multiple myeloma (MM) has been recently described. Mutational analyses of paired bone marrow (BM) MM cell DNA and ctDNA from 76 patients (n = 24, new diagnosi
Publikováno v:
Bone Marrow Transplantation. 51:722-724
Cardiovascular disease is a major cause of late morbidity and increased mortality in long-term survivors of haematological malignancy treated with stem cell transplantation (SCT).1, 2 The metabolic syndrome (MetS), a clustering of risk factors for ca
Autor:
Anna Kalff, Andrew Spencer, Malarmathy Ramachandran, D Broemeling, S Walsh, A Marziali, Brian G.M. Durie, Tiffany Khong, M Wiggin, Daniela Klarica, L Mai, Sridurga Mithraprabhu, A. Chow, Jane S Hocking
Publikováno v:
Leukemia. 31(8)
Mutational characterisation in multiple myeloma (MM) currently relies on bone marrow (BM) biopsy, which fails to capture the putative spatial and genetic heterogeneity of this multifocal disease. Analysis of plasma (PL)-derived circulating free tumou
Autor:
Tina, Pham, Sushrut, Patil, Shaun, Fleming, Sharon, Avery, Patricia, Walker, Andrew, Wei, David, Curtis, Georgia, Stuart, Daniela, Klarica, Maureen, O'Brien, Karen, Morris, Tongted, Das, Geraldine, Bollard, Jennifer, Muirhead, John, Coutsouvelis, Andrew, Spencer
Publikováno v:
Transfusion. 55(11)
Nivestim is a biosimilar approved for the same indications as Neupogen including the mobilization of autologous peripheral blood stem cells (PBSCs). The clinical efficacy and safety of Nivestim for this use have not been formally assessed in clinical